Sarcopenic obesity: Myokines as potential diagnostic biomarkers and therapeutic targets?

被引：48
|
作者：
Guo, Ai [1 ]
Li, Kai [2 ]
Xiao, Qian [1 ]
机构：
[1] Chongqing Med Univ, Dept Geriatr, Affiliated Hosp 1, Chongqing 400016, Peoples R China
[2] Chongqing Med Univ, Dept Orthoped, Affiliated Hosp 1, Chongqing 400016, Peoples R China
来源：
EXPERIMENTAL GERONTOLOGY | 2020年 / 139卷
基金：
中国国家自然科学基金;
关键词：
Myokines; Skeletal muscle; Sarcopenic obesity; Sarcopenia; Biomarker; LEUKEMIA INHIBITORY FACTOR; HUMAN SKELETAL-MUSCLE; FATTY-ACID OXIDATION; GROWTH-FACTOR; 21; BETA-AMINOISOBUTYRIC ACID; SERUM IRISIN LEVELS; FOLLISTATIN-LIKE; LEAN BODY-MASS; INSULIN-RESISTANCE; NEUROTROPHIC FACTOR;
D O I：
10.1016/j.exger.2020.111022
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
Sarcopenic obesity (SO) is a condition characterized by the occurrence of both sarcopenia and obesity and imposes a heavy burden on the health of the elderly. Controversies and challenges regarding the definition, diagnosis and treatment of SO still remain because of its complex pathogenesis and limitations. Over the past few decades, numerous studies have revealed that myokines secreted from skeletal muscle play significant roles in the regulation of muscle mass and function as well as metabolic homeostasis. Abnormalities in myokines may trigger and promote the pathogenesis underlying age-related and metabolic diseases, including obesity, sarcopenia, type 2 diabetes (T2D), and SO. This review mainly focuses on the role of myokines as potential biomarkers for the early diagnosis and therapeutic targets in SO.
引用
收藏
页数：15
相关论文
共 50 条
  • [41] Potential biomarkers and therapeutic targets in juvenile spondyloarthritis patients
    Lovro Lamot
    Mandica Vidović
    Marija Perica
    Lana Tambić Bukovac
    Kristina Gotovac
    Fran Borovečki
    Miroslav Harjaček
    Pediatric Rheumatology, 12 (Suppl 1)
  • [42] CircRNAs in colorectal cancer: potential biomarkers and therapeutic targets
    Zhang, Yuying
    Luo, Jingyan
    Yang, Weikang
    Ye, Wen-Chu
    CELL DEATH & DISEASE, 2023, 14 (06)
  • [43] MicroRNA Profiling in Asthma: Potential Biomarkers and Therapeutic Targets
    Heffler, Enrico
    Allegra, Alessandro
    Pioggia, Giovanni
    Picardi, Giuseppe
    Musolino, Caterina
    Gangemi, Sebastiano
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2017, 57 (06) : 642 - 650
  • [44] SOXC Transcription Factors as Diagnostic Biomarkers and Therapeutic Targets for Arthritis
    Ahmed, Emad A.
    Alzahrani, Abdullah M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [45] Heat shock proteins in oncology: Diagnostic biomarkers or therapeutic targets?
    Khalil, Ashraf A.
    Kabapy, Nihal F.
    Deraz, Sahar F.
    Smith, Christopher
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2011, 1816 (02): : 89 - 104
  • [46] Endothelial Microparticles in Uremia: Biomarkers and Potential Therapeutic Targets
    Favretto, Giane
    da Cunha, Regiane Stafim
    Dalboni, Maria Aparecida
    de Oliveira, Rodrigo Bueno
    Barreto, Fellype de Carvalho
    Massy, Ziad A.
    Marques Stinghen, Andrea Emilia
    TOXINS, 2019, 11 (05):
  • [47] MiRNA as potential biomarkers and therapeutic targets for gastric cancer
    Shin, Vivian Yvonne
    Chu, Kent-Man
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (30) : 10432 - 10439
  • [48] The potential of DNA modifications as biomarkers and therapeutic targets in oncology
    Jankowska, Anna M.
    Millward, Carl L.
    Caldwell, Charles W.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2015, 15 (10) : 1325 - 1337
  • [49] Ion Channels in Obesity: Pathophysiology and Potential Therapeutic Targets
    Vasconcelos, Luiz H. C.
    Souza, Iara L. L.
    Pinheiro, Lilian S.
    Silva, Bagnolia A.
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [50] Potential Therapeutic Targets of Obesity-Related Glomerulopathy
    He, Jiao
    Xiao, Yanxin
    Wang, Jun
    METABOLIC SYNDROME AND RELATED DISORDERS, 2021, 19 (07) : 367 - 371
12345